Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 2Phase NA 1Phase 2 1

Status

Completed 6

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 6

Sponsor

Cancer Type

Head & Neck 5Genitourinary 2

Conditions

Parathyroid Neoplasms 3Hyperparathyroidism, Primary 3Hyperparathyroidism 3Neoplasm Metastasis 2Prostatic Neoplasms 1Osteoporosis 1Hyperparathyroidism, Secondary 1Hypercalcemia 1Chronic Kidney Disease-Mineral and Bone Disorder 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Cinacalcet × Clear all
NCT03123406 2024-04-29

ACTIVE

Kyowa Kirin Co., Ltd.

Phase 4 Completed
750 enrolled
GenitourinaryHead & Neck

Hyperparathyroidism, Hyperparathyroidism, Secondary, Neoplasm Metastasis, Chronic Kidney Disease-Mineral and Bone Disorder

NCT03027557 2021-05-25

DENOCINA

Aalborg University Hospital

Phase 3 Completed
46 enrolled 49 charts
Head & Neck

Parathyroid Neoplasms, Hyperparathyroidism, Primary

NCT04637360 2020-11-19

Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment

Min-Sheng General Hospital

Phase NA Completed
40 enrolled
Head & Neck

Hyperparathyroidism, Neoplasm Metastasis, Osteoporosis

NCT01054079 2018-07-05

Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer

Wake Forest University Health Sciences

Phase 2 Completed
20 enrolled 10 charts
Genitourinary

Prostatic Neoplasms

NCT01460030 2017-03-03

An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

Kyowa Kirin Co., Ltd.

Phase 3 Completed
Head & Neck

Hypercalcemia, Parathyroid Neoplasms, Hyperparathyroidism, Primary

NCT00037518 2013-05-08

A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer

Amgen

Phase 4 Completed
46 enrolled
Head & Neck

Hyperparathyroidism, Parathyroid Neoplasms, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡